Pre-eclampsia screening in the first trimester – preemptive action to prevent the peril

References

• Sharp AN, Alfirevic Z. First trimester screening can predict adverse pregnancy outcomes. Prenat Diagn. 2014;34(7):660–667.
   PubMed Web of Science ®Google Scholar
• Nicolaides KH. Turning the pyramid of prenatal care. Fetal Diagn Ther. 2011;29(3):183–196.
   PubMed Web of Science ®Google Scholar
• Poon LC, Shennan A, Hyett A, et al. The International Federation of Gynecology and Obstetrics (FIGO) initiative on pre-eclampsia: a pragmatic guide for first-trimester screening and prevention. Int J Gynecol Obstet. 2019; 145(S1):1–33.
   PubMed Web of Science ®Google Scholar
• LeFevre ML, Force U, U.S. Preventive Services Task Force. Low-dose aspirin use for the prevention of morbidity and mortality from preeclampsia: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med. 2014;161(11):819–826.
   PubMed Web of Science ®Google Scholar
• National Institute for Health and Care Excellence. Hypertension in pregnancy: quality standard. Manchester (UK): NICE; 2013.
   Google Scholar
• Magee LA, Pels A, Helewa M, Canadian Hypertensive Disorders of Pregnancy Working Group, et al. Diagnosis, evaluation, and management of the hypertensive disorders of pregnancy: executive summary. J Obstet Gynaecol Can. 2014;36(5):416–441.
   PubMedGoogle Scholar
• American College of Obstetricians and Gynecologists. Low-dose aspirin use during pregnancy. ACOG Committee Opinion No. 743. Obstet Gynecol. 2018;132:e44–e52.
   PubMed Web of Science ®Google Scholar
• World Health Organization, Department of Reproductive Health and Research, Department of Maternal, Newborn, Child and Adolescent Health, Department of Nutrition for Health and Development. WHO recommendations for prevention and treatment of pre-eclampsia and eclampsia. Switzerland: World Health Organization, 2011.
   Google Scholar
• O'Gorman N, Wright D, Poon LC, et al. Multicentre screening for pre‐eclampsia by maternal factors and biomarkers at 11–13 weeks’ gestation: comparison with NICE guidelines and ACOG recommendations. Ultrasound Obstet Gynecol. 2017;49(6):756–760.
   PubMed Web of Science ®Google Scholar
• Cotechini T, Komisarenko M, Sperou A, et al. Inflammation in rat pregnancy inhibits spiral artery remodeling leading to fetal growth restriction and features of preeclampsia. J Exp Med. 2014;211(1):165–179.
   PubMed Web of Science ®Google Scholar
• Stanhewicz AE, Jandu S, Santhanam L, et al. Increased angiotensin II sensitivity contributes to microvascular dysfunction in women who have had preeclampsia. Hypertension. 2017;70(2):382–389.
   PubMed Web of Science ®Google Scholar
• Verdonk K, Saleh L, Lankhorst S, et al. Association studies suggest a key role for endothelin-1 in the pathogenesis of preeclampsia and the accompanying renin-angiotensin-aldosterone system suppression. Hypertension. 2015;65(6):1316–1323.
   PubMed Web of Science ®Google Scholar
• Thilaganathan B, Kalafat E. Cardiovascular System in Preeclampsia and Beyond. Hypertension. 2019;73(3):522–531.
   PubMed Web of Science ®Google Scholar
• McGinnis R, Steinthorsdottir V, Williams NO, GOPEC Consortium, et al. Variants in the fetal genome near FLT1 are associated with risk of preeclampsia. Nat Genet. 2017;49(8):1255–1260.
   PubMed Web of Science ®Google Scholar
• Akolekar R, Syngelaki A, Poon L, et al. Competing risks model in early screening for preeclampsia by biophysical and biochemical markers. Fetal Diagn Ther. 2013;33(1):8–15.
   PubMed Web of Science ®Google Scholar
• Lefebvre J, Demers S, Bujold E, et al. Comparison of two different sites of measurement for transabdominal uterine artery Doppler velocimetry at 11–13 weeks. Ultrasound Obstet Gynecol. 2012; 40(3):288–292.
   PubMed Web of Science ®Google Scholar
• Khong SL, Kane SC, Brennecke SP, et al. First-trimester uterine artery doppler analysis in the prediction of later pregnancy complications. Dis Markers. 2015;2015:679730.
   PubMed Web of Science ®Google Scholar
• Sotiriadis A, Hernandez‐Andrade E, da Silva Costa F, ISUOG CSC Pre-eclampsia Task Force, et al. ISUOG practice guidelines: role of ultrasound in screening for and follow-up of pre-eclampsia. Ultrasound Obstet Gynecol. 2019;53(1):7–22.
   PubMed Web of Science ®Google Scholar
• Plasencia W, Barber MA, Alvarez EE, et al. Comparative study of transabdominal and transvaginal uterine artery doppler pulsatility indices at 11–13 + 6 weeks. Hypertension Preg. 2011;30(4):414–420.
   PubMed Web of Science ®Google Scholar
• Sunjaya AF, Sunjaya AP. Evaluation of serum biomarkers and other diagnostic modalities for early diagnosis of preeclampsia. J Family Reprod Health. 2019;13(2):56–69.
   PubMedGoogle Scholar
• Tarca AL, Romero R, Benshalom-Tirosh N, et al. The prediction of early preeclampsia: results from a longitudinal proteomics study. PLoS One. 2019;14(6):e0217273.
   PubMed Web of Science ®Google Scholar
• Corrie M-W, Silverwood RJ, de Stavola BL, et al. Antenatal blood pressure for prediction of pre-eclampsia, preterm birth, and small for gestational age babies: development and validation in two general population cohorts. BMJ. 2015;351:h5948.
   PubMedGoogle Scholar
• Poon LC, Zymeri NA, Zamprakou A, et al. Protocol for measurement of mean arterial pressure at 11–13 weeks' gestation. Fetal Diagn Ther. 2012;31(1):42–48.
   PubMed Web of Science ®Google Scholar
• Rolnik DL, Wright D, Poon LCY, et al. ASPRE trial: performance of screening for preterm pre-eclampsia. Ultrasound Obstet Gynecol. 2017;50(4):492–495.
   PubMed Web of Science ®Google Scholar
• Ayala DE, Ucieda R, Hermida RC. Chronotherapy with low-dose aspirin for prevention of complications in pregnancy. Chronobiol Int. 2013;30(1–2):260–279.
   PubMed Web of Science ®Google Scholar
• Li C, Raikwar NS, Santillan MK, et al. Aspirin inhibits expression of sFLT1 from human cytotrophoblasts induced by hypoxia, via cyclo-oxygenase 1. Placenta. 2015;36(4):446–453.
   PubMed Web of Science ®Google Scholar
• Bujold E, Roberge S, Nicolaides KH. Low-dose aspirin for prevention of adverse outcomes related to abnormal placentation. Prenat Diagn. 2014;34(7):642–648.
   PubMed Web of Science ®Google Scholar
• Beaufils M, Uzan S, Donsimoni R, et al. Prevention of pre-eclampsia by anti-platelet therapy. Lancet. 1985;325(8433):840–842.
   Google Scholar
• Bujold E, Roberge S, Lacasse Y, et al. Prevention of preeclampsia and intrauterine growth restriction with aspirin started in early pregnancy: a meta-analysis. Obstet Gynecol. 2010;116(2 Pt 1):402–414.
   PubMed Web of Science ®Google Scholar
• Rolnik DL, Wright D, Poon LC, et al. Aspirin versus placebo in pregnancies at high risk for preterm preeclampsia. N Engl J Med. 2017;377(7):613–622.
   PubMed Web of Science ®Google Scholar
• Roberge S, Bujold E, Nicolaides KH. Aspirin for the prevention of preterm and term preeclampsia: systematic review and metaanalysis. Am J Obstet Gynecol. 2018;218(3):287–293.e1.
   PubMed Web of Science ®Google Scholar
• Chaemsaithong P, Cuenca-Gomez D, Plana MN, et al. Does low-dose aspirin initiated before 11 weeks’ gestation reduce the rate of preeclampsia? Am J Obstet Gynecol. [article in press]. Forthcoming. 2020;222(5):437–50.
   PubMed Web of Science ®Google Scholar
• Hernandez RK, Werler MM, Romitti P, et al. Nonsteroidal anti-inflammatory drug use among women and the risk of birth defects. Am J Obstet Gynecol. 2012;206(3):228 e.1–8.
   PubMed Web of Science ®Google Scholar
• Roberge S, Nicolaides KH, Demers S, et al. Prevention of perinatal death and adverse perinatal outcome using low‐dose aspirin: a meta‐analysis. Ultrasound Obstet Gynecol. 2013;41(5):491–499.
   PubMed Web of Science ®Google Scholar
• Li Y, Lorca R, Su E. Molecular and cellular underpinnings of normal and abnormal human placental blood flows. J Mol Endocrinol. 2018;60(1):R9–R22.
   PubMed Web of Science ®Google Scholar
• Navaratnam K, Alfirevic A, Alfirevic Z. Low dose aspirin and pregnancy: how important is aspirin resistance? BJOG. 2016;123(9):1481–1487.
   PubMed Web of Science ®Google Scholar
• Atallah A, Lecarpentier E, Goffinet F, et al. Aspirin for prevention of preeclampsia. Drugs. 2017;77(17):1819–1831.
   PubMed Web of Science ®Google Scholar
• De Berardis G, Lucisano G, D’Ettorre A, et al. Association of aspirin use with major bleeding in patients with and without diabetes. JAMA. 2012;307(21):2286–2294.
   PubMed Web of Science ®Google Scholar
• Roberge S, Bujold E, Nicolaides KH. Meta-analysis on the effect of aspirin use for prevention of preeclampsia on placental abruption and antepartum hemorrhage. Am J Obstet Gynecol. 2018;218(5):483–489.
   PubMed Web of Science ®Google Scholar
• Shintaku K, Hori S, Satoh H, et al. Prediction and evaluation of fetal toxicity induced by NSAIDs using transplacental kinetic parameters obtained from human placental perfusion studies. Br J Clin Pharmacol. 2012;73(2):248–256.
   PubMed Web of Science ®Google Scholar
• Hofmeyr GJ, Lawrie TA, Atallah AN, et al. Calcium supplementation during pregnancy for preventing hypertensive disorders and related problems. Cochrane Database Syst Rev. 2010;8:Cd001059.
   Google Scholar
• McLaughlin K, Scholten RR, Parker JD, et al. Low molecular weight heparin for the prevention of severe preeclampsia: where next? Br J Clin Pharmacol. 2018;84(4):673–678.
   PubMed Web of Science ®Google Scholar
• Francisco C, Wright D, Benkő Z, et al. Hidden high rate of pre-eclampsia in twin compared with singleton pregnancy. Ultrasound Obstet Gynecol. 2017;50(1):88–92.
   PubMed Web of Science ®Google Scholar
• Rizzo G, Pietrolucci ME, Aiello E, et al. Uterine artery Doppler evaluation in twin pregnancies at 11 + 0 to 13 + 6 weeks of gestation. Ultrasound Obstet Gynecol. 2014;44(5):557–561.
   PubMed Web of Science ®Google Scholar
• Svirsky R, Levinsohn-Tavor O, Feldman N, et al. First- and second-trimester maternal serum markers of pre-eclampsia in twin pregnancy. Ultrasound Obstet Gynecol. 2016;47(5):560–564.
   PubMed Web of Science ®Google Scholar
• Francisco C, Wright D, Benkő Z, et al. Competing-risks model in screening for pre-eclampsia in twin pregnancy according to maternal factors and biomarkers at 11–13 weeks’ gestation. Ultrasound Obstet Gynecol. 2017;50(5):589–595.
   PubMed Web of Science ®Google Scholar
• Bergeron TS, Roberge S, Carpentier C, et al. Prevention of preeclampsia with aspirin in multiple gestations: a systematic review and meta-analysis. Am J Perinatol. 2016;33(6):605–610.
   PubMed Web of Science ®Google Scholar
• Kane SC. First trimester screening for pre-eclampsia. Obstet Med. 2016;9(3):106–112.
   PubMed Web of Science ®Google Scholar
• Zakiyah N, Postma MJ, Baker PN, Improved Consortium, et al. Pre-eclampsia diagnosis and treatment options: a review of published economic assessments. Pharmacoeconomics. 2015;33(10):1069–1082.
   PubMed Web of Science ®Google Scholar
• Ghi T, Dall'Asta A, Valensise H. Antenatal care of preeclampsia: from the inverted pyramid to the arrow model? Fetal Diagn Ther. 2018;44(2):81–84.
   PubMed Web of Science ®Google Scholar